Triton Biosystems


Public lists: Medical Devices (6146)

Triton Biosystems merged with Oncologic to create Aduro BioTech. Aduro will focus on the development of its and minimally invasive cancer therapies, which use patented iron oxide nano-particles to target and kill solid tumor cancers. The nano-particles are engineered to efficiently generate high levels of heat when exposed to field, and this heat kills tumor cells without the toxicity or collateral damage that result from traditional chemotherapy or radiation treatments.

Triton Biosystems merged with Oncologic to create Aduro BioTech. Aduro will focus on the development of its and minimally invasive cancer therapies, which use patented iron oxide nano-particles to target and kill solid tumor cancers. The nano-partic...Show all

Company (Acquired)

Phone: 978-606-2900

Fax:

200 Turnpike Road
Chelmsford, 01824
Massachusetts, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Triton Biosystems $3.5M Jun 10, 2008
See all 15 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Triton Biosystems Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 2 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors
See all 15 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)